Primary Myelofibrosis Completed Phase 1 Trials for Imatinib (DB00619)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00025415Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionTreatment